GemVax&KAEL Co.Ltd (082270) — Capital Reinvestment Ratio
Latest as of December 2025:
0.14x
GemVax&KAEL Co.Ltd (082270) has a Capital Reinvestment Ratio of 0.14x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩10.34 Billion) in capital expenditures (₩1.43 Billion). See GemVax&KAEL Co.Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.14x
Capex / Operating Cash Flow
Operating Cash Flow
₩10.34 Billion
KRW
Capital Expenditures
₩1.43 Billion
KRW
Data as of
Dec 2025
Most recent filing
GemVax&KAEL Co.Ltd Capital Reinvestment Ratio (2011–2025)
This chart tracks GemVax&KAEL Co.Ltd's Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for GemVax&KAEL Co.Ltd (2011–2025)
Year-by-year Capital Reinvestment Ratio for GemVax&KAEL Co.Ltd from 2011 to 2025. For live market cap and broader valuation context, see GemVax&KAEL Co.Ltd (082270) total market value.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.91x | ₩1.11 Billion | ₩2.11 Billion | ▼ -19.6% |
| 2023 | 2.37x | ₩3.57 Billion | ₩8.46 Billion | ▲ +219.2% |
| 2020 | 0.74x | ₩13.95 Billion | ₩10.37 Billion | ▲ +502.4% |
| 2014 | 0.12x | ₩10.64 Billion | ₩1.31 Billion | ▼ -70.9% |
| 2011 | 0.42x | ₩7.42 Billion | ₩3.15 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow